Index by author

September 01, 1995; Volume 62, Issue 5

    Aaron Brzezinski

  • Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease

    Donald G. Vidt, MD, Aaron Brzezinski, MD, George B. Rankin, MD, Douglas L. Seidner, MD and Bret A. Lashner, MD, MPH
    • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 317-323;

    • Sulfasalazine, a 5-ASA agent, is the anti-inflammatory agent of choice for ulcerative colitis and Crohn's disease. Newer delayed-release formulations can also be appropriate first-line agents.

    • Bret A. Lashner

  • Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease

    Donald G. Vidt, MD, Aaron Brzezinski, MD, George B. Rankin, MD, Douglas L. Seidner, MD and Bret A. Lashner, MD, MPH
    • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 317-323;

    • Sulfasalazine, a 5-ASA agent, is the anti-inflammatory agent of choice for ulcerative colitis and Crohn's disease. Newer delayed-release formulations can also be appropriate first-line agents.

    • Brian F. Mandell

  • A 47-year-old woman with a swollen leg

    David L. Longworth, MD, James K. Stoller, MD, Rochelle Rosian, MD and Brian F. Mandell, MD, PhD
    • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 281-284;

    • A self-test featuring a challenging clinical presentation.

    • Dianne Litwin

  • Asthma: current controversies and emerging therapies

    Mani S. Kavuru, MD, Lily Pien, MD, Dianne Litwin, MD, Serpil Erzurum, MD and Muzaffar Ahmad, MD
    • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 293-304;

    • Anti-inflammatory drugs for maintenance therapy, use of beta agonists, emergency management, immunotherapy, and newer therapies.

    • Douglas L. Seidner

  • Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease

    Donald G. Vidt, MD, Aaron Brzezinski, MD, George B. Rankin, MD, Douglas L. Seidner, MD and Bret A. Lashner, MD, MPH
    • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 317-323;

    • Sulfasalazine, a 5-ASA agent, is the anti-inflammatory agent of choice for ulcerative colitis and Crohn's disease. Newer delayed-release formulations can also be appropriate first-line agents.

    • Eric A. Klein

  • An update on prostate cancer

    Maurie Markman, MD and Eric A. Klein, MD
    • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 325-338;

    • The diagnosis and treatment of prostate cancer, including the role of screening and treatment strategies for localized and advanced tumors.

    • Fetnat M. Fouad-Tarazi

  • Using the tilt test to diagnose cause of syncope

    Fetnat M. Fouad-Tarazi, MD
    • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 339-341;

    • George B. Rankin

  • Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease

    Donald G. Vidt, MD, Aaron Brzezinski, MD, George B. Rankin, MD, Douglas L. Seidner, MD and Bret A. Lashner, MD, MPH
    • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 317-323;

    • Sulfasalazine, a 5-ASA agent, is the anti-inflammatory agent of choice for ulcerative colitis and Crohn's disease. Newer delayed-release formulations can also be appropriate first-line agents.

    • Lily Pien

  • Asthma: current controversies and emerging therapies

    Mani S. Kavuru, MD, Lily Pien, MD, Dianne Litwin, MD, Serpil Erzurum, MD and Muzaffar Ahmad, MD
    • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 293-304;

    • Anti-inflammatory drugs for maintenance therapy, use of beta agonists, emergency management, immunotherapy, and newer therapies.

    • Luther T. Clark

  • Coronary heart disease in African Americans: primary and secondary prevention

    Luther T. Clark, MD and Obinnaya Emerole, MD
    • Cleveland Clinic Journal of Medicine September 1995, 62 (5) 285-292;

    • How physicians can help improve the cardiovascular health of their black patients, who have a high level of CHD risk factors.

Previous
Next
  • 1
  • 2
Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine

Cleveland Clinic Journal of Medicine

Vol. 62, Issue 5

1 Sep 1995

Table of Contents Table of Contents (PDF) Index by author

Sign up for alerts
More...
More...